In a historical cohort of patients undergoing mitral valve replacement with a Starr-Edwards prosthesis, early mortality was high at 23.7%.
High early mortality in historical Starr-Edwards mitral replacement cautions against direct application to current practice; leaves open effects of modern surgical advances.
A survey is presented of the long-termfollow-up ofagroup ofpatients who underwent mitral valve replacement with Starr-Edwards prosthesis. The early mortality (up to 3 monthsfrom operation) was 40 (23 7%), leaVing 128 for follow-up. This rangedfrom a minimum period of 6 months up to as long as 72 years, and 46 have been observed for more than 3 years.
No takes yet. Share an insight, caveat, or question.
Barclay et al. (1972) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: